[Is chemotherapy still an option in oncogene-addicted non-small cell lung cancer? No].
With the emergence of molecular targeted therapies in the management of non-small cell lung cancer, the role of conventional chemotherapy can be questioned. This article presents the key arguments against the use of cytotoxics in presence of a targetable alteration.